勘误：2-吡咯烷酮和琥珀酰亚胺作为γ-氨基丁酸转氨酶缺乏症的临床筛查生物标志物：抗癫痫药物影响准确诊断。
Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis.
作者信息
Kennedy Adam D, Pappan Kirk L, Donti Taraka, Delgado Mauricio R, Shinawi Marwan, Pearson Toni S, Lalani Seema R, Craigen William J, Sutton V Reid, Evans Anne M, Sun Qin, Emrick Lisa T, Elsea Sarah H
机构信息
Metabolon, Inc., Morrisville, NC, United States.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States.
出版信息
Front Neurosci. 2020 Jan 29;13:1344. doi: 10.3389/fnins.2019.01344. eCollection 2019.
Abstract
[This corrects the article DOI: 10.3389/fnins.2019.00394.].
摘要
[本文更正了文章的数字对象标识符：10.3389/fnins.2019.00394。]
Zotero 插件